ChartRow logo
$781.49-1.48%
as of market close, Sep 11, 2026
☾ AH
PeersMRNALLYUNHJNJMRKABBV

Regeneron Pharmaceuticals Inc. trailing returns

Regeneron Pharmaceuticals Inc.'s 10-year annualized return is +7.5% per year (+105.2% cumulative). How Regeneron Pharmaceuticals Inc. (REGN) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through September 11, 2026 — cumulative and annualized, with dividends on or off.

Trailing returns by period#

To 2026-09-11. Annualized (CAGR) for windows of a year or more.

PeriodPathAnnualizedCumulative
1 day-1.5%
1 week-7.3%
1 month-2.0%
YTD+1.6%
1 year
+41.3%
+41.3%
5 years
+3.9%
+21.3%
10 years
+7.5%
+105.2%
20 years
+21.5%
+4836.6%
Since inception (1991)
+10.8%
+3634.3%

Growth of REGN

Actual index level (solid); dashed lines are each window's constant-rate path from start to today.

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-09-11). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from REGN's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Regeneron Pharmaceuticals Inc.'s 10-year return?
Over the last 10 years, Regeneron Pharmaceuticals Inc. (REGN) returned about +7.5% a year annualized (+105.2% cumulative total return).
What is Regeneron Pharmaceuticals Inc.'s 20-year annualized return?
Over the last 20 years, Regeneron Pharmaceuticals Inc. (REGN) compounded at about +21.5% a year (+4836.6% cumulative).
What is Regeneron Pharmaceuticals Inc.'s return since inception?
Since 1991, Regeneron Pharmaceuticals Inc. (REGN) has compounded at about +10.8% a year — +3634.3% in total.

More on Regeneron Pharmaceuticals Inc.